Jacob T. Lambdin

George Washington University Hospital

Papers

1

Total Citations

3

H-Index

1

About

Dr. Jacob T. Lambdin is a surgical oncologist whose research focuses on the diagnosis and management of rare gastrointestinal malignancies, with a particular emphasis on histiocytic disorders and minimally invasive surgical techniques. His most notable contribution is the first documented case of Rosai-Dorfman disease (RDD) of the rectum, a condition so rare that fewer than 20 gastrointestinal cases have ever been reported. In his landmark 2022 paper, Dr. Lambdin not only described a novel robotic resection approach for this challenging presentation but also identified previously unreported genetic point mutations associated with the disease, offering new insights into its molecular pathogenesis. While his work on RDD has garnered early citations, his broader impact lies in advancing the surgical treatment of ultrarare tumors through precision techniques. Dr. Lambdin’s research bridges a critical gap between genetic discovery and surgical innovation, providing a roadmap for managing diseases where clinical evidence is scarce. His contributions are particularly valuable for surgeons and oncologists confronting diagnostic dilemmas in gastrointestinal histiocytic disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Rosai-Dorfman Disease of the Rectum: Newly Identified Genetic Point Mutations and Robotic Resection
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: George Washington University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago